AVICANNA INC.
TORONTO, A6 · Founded 2016 · CIK 0001811059 · Biotech · Public
Cannabinoid-based pharmaceutical products using evidence-based delivery systems
avicanna.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $10M
- 6 Form D · Oct 2022
- 48 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 3 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $185,000 | |
| Private capital raised | Form D · SEC | $2,089,079 | |
| Private capital raised | Form D · SEC | $4,511,724 | |
| Private capital raised | Form D · SEC | $78,811 | |
| Private capital raised | Form D · SEC | $1,099,939 | |
| Private capital raised | Form D · SEC | $2,039,427 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3361 | CORMEDIX, INC. | — | $3.5M |
| 3362 | ACTINOBAC BIOMED, INC. | — | $3.4M |
| 3363 | Vernal Biosciences, Inc. | — | $22M |
| 3364 | AVICANNA INC. | — | $10M |
| 3365 | Adipo Therapeutics, LLC | — | $6.0M |
| 3366 | Adcendo | — | — |
| 3367 | SYNERGYS BIOTHERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Amza AliExecutive Officer
- Aras AzadianDirector · Executive Officer
- Giancarlo Davila CharDirector
- Janet GieesselmanDirector
- Dr. Assad KazeminyDirector
- Benjamin LeavenworthDirector
- Eileen McCormackDirector
- John McVicarDirector
- Lucas NosigliaExecutive Officer
- Chandrakant PanchalDirector
- Dr. Chandrakant PanchalDirector
- Setu PurohitDirector · Executive Officer
- Dave SohiExecutive Officer
- Davender SohiExecutive Officer
- David WhiteDirector
- Flavio ZaclisDirector
Patents
- Topical Cannabinoid Compositions For Clear Skingranted
- Oral Cannabinoid Compositions And Methods For Treating Neurological Diseases And Disordersapplication
- Topical Cannabinoid Compositions and Methods for Treating Skin Diseasesapplication
- Deep Penetrating Topical Cannabinoid Compositions And Methods For Treating Musculoskeletal Inflammation And Paingranted
- Oral Cannabinoid Compositions And Methods For Treating Neuropathic Paingranted
- Topical Skin Care Composition And Methods For Treating Eczemaapplication
- Topical Cannabinoid Compositions And Methods For Treating Skin Diseasesapplication
- Deep Penetrating Topical Cannabinoid Compositions And Methods For Treating Musculoskeletal Inflammation And Painapplication
- Topical Cannabinoid Compositions For Clear Skinapplication
- Oral Cannabinoid Compositions And Methods For Treating Neuropathic Painapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.